ANTIBIOTICI “DISTRUGGONO” IL MICROBIOTA INTESTINALE: UNA BUONA REVIEW

Antibiotics as Major Disruptors of Gut Microbiota Jaime Ramirez et al. Advances in culture-independent research techniques have led to an increased understanding of the gut microbiota and the role it plays in health and disease. The intestine is populated by a complex microbial community that is organized around a network of metabolic interdependencies. It is…

INTELLIGENZA ARTIFICIALE E MEDICO DI FAMIGLIA: UN GRANDE ARTICOLO DA “SALUTE INTERNAZIONALE”

Intelligenza artificiale e medicina generale Giampaolo Collecchia “… La filosofia arriva sempre troppo tardi. Come pensiero nel mondo, essa appare per la prima volta nel tempo, dopo che la realtà ha compiuto il suo processo di formazione ed è bell’e fatta… Quando la filosofia dipinge a chiaroscuro, allora un aspetto della vita è invecchiato, e,…

BARRIERA MUCOSA: IL VERO AGENTE PROVOCATORE PER LE IBD

The intestinal barrier, an arbitrator turned provocateur in IBD Mehandru S, and Colombel JF Key studies published in 2020 demonstrate that an impaired intestinal barrier precedes clinical diagnosis of inflammatory bowel disease (IBD) by years. Furthermore, studies identify novel regulators of the intestinal barrier, including intestinal macrophages and diurnal variations of diet–microbiome interactions, which could…

NUOVO STRUMENTO PER VALUTARE LA DIFFERENZA CLINICA NELLE META-ANALISI !

A new tool to assess Clinical Diversity In Meta‐analyses (CDIM) of interventions M Barbateskovic et al. HIGHLIGHTS What is new? This paper describes Clinical Diversity In Meta-analyses (CDIM), the first tool scientifically developed to assess clinical diversity in meta-analyses Key findings: CDIM was developed using a rigorous methodology and consists of four domains: setting diversity;…